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Introduction {#sec005}
============

Modern treatment modalities for breast cancer, including surgery, targeted therapy, and chemotherapy, have allowed patients to survive longer than previously. However, more than 60% of survivors develop climacteric syndrome, with symptoms such as hot flush\[[@pone.0180918.ref001], [@pone.0180918.ref002]\]. The prevalence of menopause-related sleep disturbances also range from 18.6--56.6%\[[@pone.0180918.ref003]--[@pone.0180918.ref005]\]. These symptoms can be clinically significant, negatively impact quality of life, and limit daily activities.

Hormone therapy (HT) is considered the most effective treatment for hot flush, but this treatment is often unsuitable for breast cancer survivors because many of them have already undergone HT, and exposure to estrogen increases the risk of breast cancer recurrence and cardiovascular disease\[[@pone.0180918.ref006]--[@pone.0180918.ref008]\]. Accordingly, many breast cancer patients with climacteric syndrome seek a complementary and alternative medicine (CAM) to relieve their symptoms, such as special diets, yoga, herbal therapies, acupuncture, and others\[[@pone.0180918.ref009], [@pone.0180918.ref010]\].

The mechanism by which acupuncture leads to physiological or clinical changes is still unclear, but it is widely accepted as a safe treatment\[[@pone.0180918.ref011]\]. Moreover, the understanding and practice of real-world acupuncture varies considerably. On the one hand, traditional Chinese medicine proposes that acupuncture alleviates pain and treats symptoms by regulating meridian energy (Qi); on the other hand, modern Western medicine has examined the mechanism of acupuncture based on changes in neurophysiologic and neuro-hormonal activities\[[@pone.0180918.ref012]\]. Some studies suggest that acupuncture increases endorphin activity, thereby modulating thermoregulation in the hypothalamus, and counteracting the disturbed thermoregulation of patients suffering from vasomotor syndromes\[[@pone.0180918.ref013]\]. Aside from the unknown mechanism and diverse theories of acupuncture\[[@pone.0180918.ref014]\], 5 to 71% of breast cancer patients choose to undergo acupuncture\[[@pone.0180918.ref015], [@pone.0180918.ref016]\] due to its safety, high accessibility, and the minimal risk of causing endometrial problems.

Recent studies have examined the effect of acupuncture on alleviation of hot flush and menopause syndromes in breast cancer patients. In recent years, some randomized controlled trials (RCTs) investigated the efficacy of acupuncture in reducing hot flush, sleeping disorders, quality of life, joint pain, and other symptoms of breast cancer patients\[[@pone.0180918.ref017], [@pone.0180918.ref018]\]. Different studies have used different control treatments (sham acupuncture, hormone therapy, applied relaxation, etc.) for comparison, to determine whether acupuncture outperforms other kinds therapy, or if the benefit is only due to the placebo effect. Although the data tends to show that acupuncture has a positive effect, the results are not totally convincing or consistent among all trials.

Accordingly, we reviewed all relevant studies and conducted a meta-analysis of RCTs to investigate the efficacy of acupuncture on hot flush and other symptoms of medical menopause in patients with breast cancer.

Methods {#sec006}
=======

Data sources and searches {#sec007}
-------------------------

The conduct of this systematic review complied with the PRISMA Statement\[[@pone.0180918.ref019], [@pone.0180918.ref020]\] to ensure transparent and complete reporting. The following 7 databases were searched for relevant RCTs, with no language restrictions, from their inception dates to March 2017: MEDLINE (Ovid), EMBASE, Cochrane CENTRAL, CINAHL Plus with Full Text, Web of Science Core Collection, Index to Taiwan Periodical Literature System, and WHO International Clinical Trials Registry Platform (ICTRP). The reference lists of eligible articles were also reviewed to identify additional studies for possible inclusion. We also established e-mail alerts to identify newly released studies from the different databases that were within the scope of our review.

The keywords, hot flush, menopause symptoms, breast cancer, and acupuncture, used in the search included their synonyms (text words) and controlled vocabulary (MESH terms etc.) when available. Based on the MEDLINE (Ovid) search strategy, queries were revised for searches of the other databases. We adopted highly sensitive search syntaxes for identifying randomized trials. [S1 Appendix](#pone.0180918.s001){ref-type="supplementary-material"} shows the search strategy.

Eligibility criteria {#sec008}
--------------------

All eligible studies examined women with breast cancer, and measured the severity of hot flush and menopause symptoms. Only studies that used true needle acupuncture were enrolled, while other studies which adopted Transcutaneous electrical nerve stimulation (TENS) or other acupoints stimulation were excluded. To improve consistency, only studies that measured the frequency and severity of hot flush and the Kupperman index (a menopause rating scale)\[[@pone.0180918.ref021]\] were subjected to meta-analysis.

Study and data extraction {#sec009}
-------------------------

Searches of the 7 databases and additional sources led to the identification of 453 potentially relevant articles. The titles and abstracts that fulfilled the criteria of our study were independently read by two reviewers (Chien and Liu), and the full texts of articles that met these criteria were obtained. Final decisions on inclusion were made after examination of the full manuscripts. In cases of duplicate publications, the most recent and complete versions were selected. A total of 440 articles were excluded, 159 because they were duplicated, 229 that were considered irrelevant based on the titles and abstracts, and 52 full texts that were not RCTs, having non-matched coverage, or were trial registers / conference abstracts only were also excluded. We also contacted some authors to ensure that studies with only abstracts in some conferences yet have been published with completed data are included. ([Fig 1](#pone.0180918.g001){ref-type="fig"}).

![Selection of randomized controlled trials (based on PRISMA).](pone.0180918.g001){#pone.0180918.g001}

There were 13 unique studies ultimately included. 7 studies compared acupuncture with sham acupuncture: Bao-2014\[[@pone.0180918.ref022]\], Hervik-2014\[[@pone.0180918.ref023]\], Bokmand-2013\[[@pone.0180918.ref024]\], Liljegren-2012\[[@pone.0180918.ref025]\], Hervik-2009\[[@pone.0180918.ref026]\], Deng-2007\[[@pone.0180918.ref027]\], Mao-2015\[[@pone.0180918.ref028]\]; 3 studies compared acupuncture with relaxation or self-care: Lesi-2016\[[@pone.0180918.ref029]\], Nedstrand-2006\[[@pone.0180918.ref030]\], Nedstrand-2005\[[@pone.0180918.ref031]\]; and 4 studies compared acupuncture with therapy by hormone or other medications: Frisk-2012\[[@pone.0180918.ref032]\], Frisk-2008\[[@pone.0180918.ref033]\], Walker-2010\[[@pone.0180918.ref034]\], and Mao-2015\[[@pone.0180918.ref028]\].

The risk of bias and quality assessment {#sec010}
---------------------------------------

The quality of each enrolled study was assessed independently by 2 reviewers, using the criteria recommended in the *Cochrane Handbook for Systematic Reviews of Interventions*, *version 5*.*1*.*0*\[[@pone.0180918.ref035]\]. Six domains were assessed: *(i)* generation of randomization, *(ii)* allocation concealment, *(iii)* blinding of participants and personnel, *(iv)* blinding of outcome assessment, *(v)* incomplete outcome data, and *(vi)* selective outcome reporting. The modified Jadad scale was used to assess the quality of the included studies\[[@pone.0180918.ref036], [@pone.0180918.ref037]\]. [Table 1](#pone.0180918.t001){ref-type="table"} shows the risks of the bias in each of these 6 domains. We also contacted authors to identify additional studies and asked them for providing methodological details when data were missing.

10.1371/journal.pone.0180918.t001

###### Risk of bias in the included randomized controlled trials.

![](pone.0180918.t001){#pone.0180918.t001g}

  Author^\[ref\]^, Year                       Randomization   Allocation Concealment   Patients Blinding   Assessor Blinding   Incomplete Outcome Data Addressed   Selective Outcome Reporting   Modified Jadad Scale[\*](#t001fn001){ref-type="table-fn"}
  ------------------------------------------- --------------- ------------------------ ------------------- ------------------- ----------------------------------- ----------------------------- -----------------------------------------------------------
  Lesi\[[@pone.0180918.ref029]\], 2016        Low             Low                      Low                 Low                 Low                                 Low                           5
  Mao\[[@pone.0180918.ref028]\], 2015         Low             Low                      Low                 High                Low                                 Low                           3
  Bao\[[@pone.0180918.ref022]\], 2014         Low             Unclear                  Low                 Low                 Low                                 Unclear                       4
  Hervik\[[@pone.0180918.ref023]\], 2014      Low             Low                      Low                 Low                 Unclear                             Unclear                       4
  Bokmand\[[@pone.0180918.ref024]\], 2013     Low             Low                      Low                 Low                 Unclear                             Low                           4
  Liljegren\[[@pone.0180918.ref025]\], 2012   Low             Low                      Low                 Low                 Low                                 Unclear                       5
  Frisk\[[@pone.0180918.ref032]\], 2012       Low             Low                      Unclear             Low                 Low                                 Unclear                       4
  Walker\[[@pone.0180918.ref034]\], 2010      Low             Low                      Low                 Low                 Unclear                             Low                           3
  Hervik\[[@pone.0180918.ref026]\], 2009      Low             Low                      Low                 Low                 Low                                 Low                           5
  Frisk\[[@pone.0180918.ref033]\], 2008       Low             Low                      Low                 Low                 Low                                 Low                           5
  Deng\[[@pone.0180918.ref027]\], 2007        Low             Low                      Low                 Low                 Low                                 Unclear                       5
  Nedstrand\[[@pone.0180918.ref030]\], 2006   Low             Low                      Unclear             Low                 Low                                 Unclear                       4
  Nedstrand\[[@pone.0180918.ref031]\], 2005   Low             Unclear                  Unclear             Unclear             Low                                 Unclear                       3

\*Modified Jadad Scale: Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1--12.

Data synthesis and statistical meta-analysis {#sec011}
--------------------------------------------

To analyze the effects of acupuncture on outcomes (hot flush and menopausal symptoms), we estimated weighted mean differences (WMDs) and 95% confidence intervals (CIs) from each study using the Cochrane Collaboration software, Review Manager (RevMan) Version 5.2, for Windows. In estimating WMDs, a point estimate of zero indicated no effect, and an estimate less than zero indicated a benefit of acupuncture. Statistical heterogeneity was assessed using the Chi-square test (*p* \< 0.1) and calculation of the I^2^ statistic. We considered an I^2^ value above 50% to indicate significant heterogeneity across studies\[[@pone.0180918.ref038]\]. A random-effects model was adapted if there was significant heterogeneity among studies. Otherwise, results were obtained from a fixed-effects model.

Results {#sec012}
=======

Evaluation of quality and descriptions of the included trials {#sec013}
-------------------------------------------------------------

[Table 1](#pone.0180918.t001){ref-type="table"} shows the risk of bias in the 13 included studies. Most studies had low risk for adequate randomization, allocation, and blinding. The modified Jadad scale represents the quality of a RCT, and has a maximum of 5 points (1 point for randomization, 1 point for appropriate randomization method, 1 point for describing dropouts, 1 point for patient blinding, and 1 point for assessor blinding)\[[@pone.0180918.ref036]\]. The included studies had medium-to-high quality, in that 5 studies had scores of 5, 5 had scores of 4, and 3 had scores of 3.

The 13 prospective RCTs examined 844 patients with breast cancer ([Table 2](#pone.0180918.t002){ref-type="table"}). The sample size ranged from 31 to 120, and the average age of enrolled subjects ranged from 50 to 61 years-old. The control treatments were sham acupuncture (7 studies), applied relaxation (3 studies), and hormone or drug therapy (4 studies). Some trials had more than one control group. The heterogeneity and limited number within individual enrolled articles might contribute to some risk of bias. Nevertheless, we only included eight studies with consistent outcomes for meta-analysis in order to reduce the possible bias. ([Fig 1](#pone.0180918.g001){ref-type="fig"})

10.1371/journal.pone.0180918.t002

###### Characteristics of the included randomized controlled trials.

![](pone.0180918.t002){#pone.0180918.t002g}

  Author^\[ref\]^, Year                       Sample   Control Arm                         Intervention (Primary Acupoints)                                                                               Course (Weeks)   Measurement Tools                                     Results
  ------------------------------------------- -------- ----------------------------------- -------------------------------------------------------------------------------------------------------------- ---------------- ----------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Lesi\[[@pone.0180918.ref029]\], 2016        105      Enhance self-care                   10 acupuncture sessions once per week;SP6, LI11, CV4                                                           12               Hot flush scoreClimacteric symptomsQoL                Acupuncture significantly decrease hot flush, climacteric syndrome and improve QoL
  Mao\[[@pone.0180918.ref028]\], 2015         120      Sham acupuncture gabapentin         Twice per week for 2 weeks, then once per week for 6 more weeks,                                               8                Hot flush frequencyHot flush composite score (HFCS)   By week 8,SA produced significantly greater reduction in HFCS than did Placebo pillsBy week 24, HFCS reduction was greatest in the EA group, followed by Sham acupuncture, Placebo pill, and Gabapentin
  Bao\[[@pone.0180918.ref022]\], 2014         47       Sham acupuncture                    Weekly; CV4, CV6, CV12; LI4;MH6;GB34;ST36; KI3;BL65                                                            8                NSABP; CESD; PSQI; HADS; Euro QoL; FRDI               SA group has significant change in flush frequency and severity; HFRDI, NSABP, Euro QoL
  Hervik\[[@pone.0180918.ref023]\], 2014      61       Sham acupuncture                    A course of 15 acupuncture treatments                                                                          10               Kupperman index                                       Acupuncture has positive effect on health related QoL
  Bokmand\[[@pone.0180918.ref024]\], 2013     94       Sham acupuncture and no treatment   15--20 min weekly. HC6, KI3, SP6, LR3                                                                          12               VASEstradiol level                                    Significantly relieve hot flush and sleep disturbance
  Liljegren\[[@pone.0180918.ref025]\], 2012   84       Sham acupuncture                    20 min twice a week for 5 weeks (De-Qi required); LI4, HT6, LR3, ST36, SP6, KI7                                6                FrequencySeverity score                               No significant change in hot flush
  Frisk\[[@pone.0180918.ref032]\], 2012       45       Hormone therapy                     As standards for Reporting Interventions in Clinical Trials of Acupuncture                                     12               Hot flush scoresPGWBWHO                               Significant change of hot flush in both HT and EA group
  Walker\[[@pone.0180918.ref034]\], 2010      50       SSRI: Venlafaxine                   Twice-weekly for first 4 weeks, then weekly for 8 weeks. BL23, KI3, SP6, Du14,20, ST36, LI3, HE7.              12               Men-QoLSF12                                           Both groups: significant decrease hot flush, depression and QoL
  Hervik\[[@pone.0180918.ref026]\], 2009      59       Sham acupuncture                    30 min twice-weekly for 5 weeks then weekly for following 5 weeks. LIV3, GB20, LU7, KI3, SP6, REN4, P7, LIV8   10               Kupperman index                                       Significant improve in flush frequency
  Frisk\[[@pone.0180918.ref033]\], 2008       45       Hormone therapy                     30min twice-weekly for 2 weeks then weekly for 10 weeks                                                        12               Flush frequencyKupperman index                        Both groups noted significant change over flush frequency and depression
  Deng\[[@pone.0180918.ref027]\], 2007        72       Sham acupuncture                    Twice-weekly for 4 weeks. DU14, GB20, BL13, PC7, H6, K7, ST36, SP6                                             4                Flush frequency;                                      TA has longer benefit in reducing hot flush than SA
  Nedstrand\[[@pone.0180918.ref030]\], 2006   31       Applied relaxation                  30 min twice a week for 2 weeks then weekly for 10 weeks. (De Qi required)                                     12               VASMood scale                                         Both groups benefit from psychologic well-being;Mood improve in EA group
  Nedstrand\[[@pone.0180918.ref031]\], 2005   31       Applied relaxation                  30 min twice a week for 2 weeks then weekly for 10 weeks. (De Qi required) L15,23,32;HT7,SP6,9,LR3, PC6,GV20   12               Flush frequencyKupperman index                        Both groups have significant change in flush frequency and KI

Effect of acupuncture on the frequency and the severity of hot flush {#sec014}
--------------------------------------------------------------------

We observed significant between-study heterogeneity in the effects of acupuncture on the frequency of hot flush (times/day) (I2 = 67%), the severity of hot flush (visual analog scale) (I2 = 93%) and menopausal symptoms (menopause symptom scales) (I2 = 76%). Regarding the effect of acupuncture on the frequency of hot flush, total 124 patients were analyzed from 4 trials; no significant reduction in the frequency of hot flush was observed in subjects treated with acupuncture as compared with control subjects (-1.01 95% CI:-3.1, 1.08, *P* = 0.34; [Fig 2](#pone.0180918.g002){ref-type="fig"}). As for the 3 trials that reported data on severity of hot flush analyzed 140 patients; it indicated that acupuncture did not significantly reduce the severity of hot flush either. (Mean difference = -4.35, 95% CI:-13.10, 4.39, *P* = 0.33; [Fig 3](#pone.0180918.g003){ref-type="fig"}).

![Forest plot of the effect of acupuncture on the frequency of hot flush.\
(times/day).](pone.0180918.g002){#pone.0180918.g002}

![Forest plot of the effect of acupuncture on the severity of hot flush.\
(visual analog scale).](pone.0180918.g003){#pone.0180918.g003}

Effect of acupuncture on menopausal symptoms {#sec015}
--------------------------------------------

Six trials (207 patients) reported data on menopausal symptoms, measured by menopause symptom scales ([Fig 4](#pone.0180918.g004){ref-type="fig"}). While most studies used the Kupperman index; Lesi (2016) adopted the Greene Climacteric scales, and Bao (2014) took NSABP menopausal symptom questionnaire; the different scales measure similar items without conflictions. To make sure the consistency, we transform the scores measured in Lesi and Bao's study by proportion to match the scales of other studies. The results indicated that acupuncture significantly reduced menopausal symptoms (Mean difference = -3.28, 95% CI:-5.75, -0.80, *P* = 0.009; [Fig 4](#pone.0180918.g004){ref-type="fig"}).

![Forest plot of the effect of acupuncture on menopausal symptoms (scales).](pone.0180918.g004){#pone.0180918.g004}

Additionally, the funnel plot analysis is not eligible due to the insufficient number.

Discussion {#sec016}
==========

Most previous review studies that examined the effect of different treatments on hot flush examined hot flush frequency. We instead measured the effect of acupuncture on hot flush severity. Our results indicate that acupuncture had no significant effect on the severity of hot flush, but it did reduce general symptoms of menopause, as indicated by the Kupperman index. Below, we discuss studies with results inconsistent with the present meta-analysis, and the possible mechanism of acupuncture in relieving symptoms of menopause.

We included 3 studies that examined the effect of acupuncture on the severity of hot flush. Our meta-analysis indicated that acupuncture provided no significant improvement, leading us to ask why most individual studies showed a meaningful effect. It may be that although acupuncture had an effect, this effect was small, and because hormone therapy (the control therapy) had a similar effect in relieving hot flush, albeit with more adverse effects. The sham acupuncture may also have a positive, albeit small, effect in relieving the severity of hot flush.

Additionally, most studies used a visual analogue scale (VAS) or mood scale to evaluate the severity of hot flush. These scales may not be totally objective, because most women report an amelioration of hot flush during cold weather. The effect of seasonal changes as a possible bias in these studies should therefore be considered. Moreover, if acupuncture indeed significantly reduces the severity of hot flush, there must be some underlying mechanism. We have no evidence that acupuncture affects the level of estrogen, because most studies did not measure hormone levels. Nevertheless, some previous studies indicated no correlation between the plasma, urinary, or vaginal estrogen levels and the appearance of hot flush\[[@pone.0180918.ref039]\].

Aside from hot flush, factors such as negative mood, sensitivity to physical symptoms, sleep problems, longer duration of symptoms, and poorer health may contribute to an increased severity of vasomotor menopause syndrome. We therefore also investigated menopause symptoms, as indicated by the Kupperman index or other scales, in this meta-analysis. Our results indicated that acupuncture significantly ameliorated menopause symptoms. Most of the analyzed studies used the Kupperman index (with 21 questions), which evaluates hot flush, sleeping disorders, paresthesia, depression, joint pain, palpitation, headache, tingling, dizziness, and irritability. The results show that acupuncture provided a benefit (*p* = 0.009). We further examined the 2 studies that showed no effect^30,\ 33^. The Nedstrand et al. study reported the control and acupuncture groups both had significant amelioration of climacteric symptoms\[[@pone.0180918.ref030]\]. Similarly, the Frisk et al. study, which compared electro-acupuncture to hormone therapy, reported a benefit from both treatments, but that hormone therapy had a stronger effect\[[@pone.0180918.ref033]\].

Studies of the mechanism of hot flush indicate that estrogen depletion has an important role. Hot flush occurs in most women undergoing natural or medical menopause, and is related to cessation of ovary function\[[@pone.0180918.ref040], [@pone.0180918.ref041]\]. However, estrogen depletion is not the sole factor, because there are no differences in plasma estrogen levels between symptomatic and asymptomatic women\[[@pone.0180918.ref042], [@pone.0180918.ref043]\]. Recent studies suggest that hot flush might be related to autonomic dysfunction\[[@pone.0180918.ref044], [@pone.0180918.ref045]\], and disruption of thermoregulation in the hypothalamus, leading to increased core body temperature (Tc)\[[@pone.0180918.ref043], [@pone.0180918.ref046]\]. Other research suggested that the rate of change in plasma estrogen concentration influences the thermoregulatory system *via* the hypothalamus\[[@pone.0180918.ref047]\].

These intriguing previous studies lead us to ask: "How can acupuncture alleviate hot flush?" and "By what mechanism does acupuncture relieve menopause symptoms?" There is some evidence that acupuncture may relieve menopause symptoms and hot flush *via* altering the autonomic nervous system. Moreover, the thermo-neutral zone of women undergoing menopause may be narrowed due to elevated sympathetic activity, thus resulting in hot flush and elevation of core body temperature (Tc)\[[@pone.0180918.ref048]\]. Freedman also noted that up-regulation of the sympathetic system is an essential component of hot flush\[[@pone.0180918.ref049]\]. Hence, acupuncture might up-regulate the parasympathetic system, counter-balancing the over-excited sympathetic system, and thereby relieve menopause symptoms.

From the perspective of neurotransmitters, some evidence suggests that the decrease of estrogen correlates with the decline of endorphins in the hypothalamus. A reduced level of endorphins promotes the release of serotonin and norepinephrine, which contribute to the decline in the set-point in the thermoregulatory center of the hypothalamus, and triggers hot flush and vasomotor menopause symptoms\[[@pone.0180918.ref050], [@pone.0180918.ref051]\]. It is widely acknowledged that acupuncture can stimulate the secretion of endorphins\[[@pone.0180918.ref052]\] and alter autonomic nerve function\[[@pone.0180918.ref053], [@pone.0180918.ref054]\]. This mechanism may therefore explain how acupuncture alleviates menopause symptoms, such as joint pain, sleeping disorder, depression, and nervous system-related symptoms such as paresthesia and tingling\[[@pone.0180918.ref055]\].

Recently, some scholars proposed that Neurokinin B (NKB) administration can cause hot flushes in women as it is a hypothalamic neuropeptide binding to the neurokinin 3 receptors.\[[@pone.0180918.ref056]\]. Similar research also support that the marked changes in hypothalamic kisspeptin, neurokinin B and dynorphin (KNDy) neurons might contribute to hot flush based on the animal study noted that KNDy neurons modulate LH secretion and body temperature\[[@pone.0180918.ref057]\]. These statements remind us the acupuncture could probably improve hot flush by regulating these transmitters though there are still need more solid research\[[@pone.0180918.ref058]\].

The mechanism by which acupuncture alleviates menopause syndrome might be complex, and involve more than simply regulating cytokines and the autonomic nerve systems, yet our interpretation is reasonable and consistent with available research. Nonetheless, we cannot draw a definitive conclusion, because an insufficient number of acupuncture studies have examined biomarkers or cytokines. Future studies should focus on the underlying molecular mechanisms of acupuncture, and should attempt to reinterpret the traditional theory of meridians and qi, and identify therapeutic indications within the framework of evidence-based medicine.

Limitations {#sec017}
===========

This meta-analysis only examined RCTs to achieve higher internal validity, but there were still some limitations. First, the number of the enrolled patients in each study was small (range: 31 to 120). Second, variations among the included studies, such as use of different controls, treatment sessions and periods, acupoints, and menopause status of patients, may have led to bias. Third, some studies did not clearly state whether patients and assessors were blinded, and some did not address the presence of incomplete outcome data or whether there was selective outcome reporting. Despite these limitations, none of the studies reported severe adverse effects, although there were some minor events, such as slight bleeding and/or bruising at the site of needle insertion.

Conclusion {#sec018}
==========

This meta-analysis of women with breast cancer confirms that acupuncture had no significant effect on the severity of hot flush, but did significantly alleviate the symptoms of menopause. We conclude that acupuncture is non-inferior to hormone therapy or other applied relaxation therapies in alleviating the symptoms of menopause for its safety, non-invasive and especially considering the side effect of hormone therapy. Recent studies show that use of acupuncture does not correlate with increased levels of plasma estradiol. Considering the safety and lack of serious adverse effects associated with acupuncture, in contrast to hormone therapy, acupuncture should be considered for treating hot flush and menopause syndrome in women with breast cancer.
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